<SEC-DOCUMENT>0001214659-22-006042.txt : 20220429
<SEC-HEADER>0001214659-22-006042.hdr.sgml : 20220429
<ACCEPTANCE-DATETIME>20220429114931
ACCESSION NUMBER:		0001214659-22-006042
CONFORMED SUBMISSION TYPE:	PX14A6G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220429
DATE AS OF CHANGE:		20220429
EFFECTIVENESS DATE:		20220429

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DAVITA INC.
		CENTRAL INDEX KEY:			0000927066
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				510354549
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PX14A6G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14106
		FILM NUMBER:		22872079

	BUSINESS ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202
		BUSINESS PHONE:		310-536-2668

	MAIL ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA HEALTHCARE PARTNERS INC.
		DATE OF NAME CHANGE:	20121107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA INC
		DATE OF NAME CHANGE:	20001005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TOTAL RENAL CARE HOLDINGS INC
		DATE OF NAME CHANGE:	19950524

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Friends Fiduciary Corp
		CENTRAL INDEX KEY:			0001696940
		IRS NUMBER:				231968136
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PX14A6G

	BUSINESS ADDRESS:	
		STREET 1:		1700 MARKET STREET
		STREET 2:		SUITE 1535
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103
		BUSINESS PHONE:		2152417272

	MAIL ADDRESS:	
		STREET 1:		1700 MARKET STREET
		STREET 2:		SUITE 1535
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103
</SEC-HEADER>
<DOCUMENT>
<TYPE>PX14A6G
<SEQUENCE>1
<FILENAME>p429220px14a6g.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><IMG SRC="ff_logo.jpg" ALT="">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NAME OF REGISTRANT: DAVITA INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NAME OF PERSON RELYING ON EXEMPTION: FRIENDS FIDUCIARY CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ADDRESS OF PERSON RELYING ON EXEMPTION: 1700 MARKET STREET, SUITE
1535, PHILADELPHIA, PA 19103</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 29, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To DaVita Stockholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Friends Fiduciary Corporation <B>seeks your support for Proposal 4
at the stockholder meeting on June 9, 2022.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The proposal asks DaVita to prepare an annual report on its political
spending.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Resolved</B>, that the shareholders of DaVita Inc.&nbsp; (&ldquo;DaVita&rdquo;
    or &ldquo;Company&rdquo;) hereby request the Company to prepare and semiannually update a report, which shall be presented to the pertinent
    board of directors committee and posted on the Company&rsquo;s website, disclosing the Company&rsquo;s:&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) Policies and procedures for making electoral
    contributions and expenditures (direct and indirect) with corporate funds, including the board&rsquo;s role (if any) in that process;
    and&nbsp;&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) Monetary and non-monetary contributions or
    expenditures that could not be deducted as an &ldquo;ordinary and necessary&rdquo; business expense under section 162(e)(1)(B) of the
    Internal Revenue Code, including (but not limited to) contributions or expenditures on behalf of candidates, parties, and committees and
    entities organized and operating under section 501(c)(4) of the Internal Revenue Code, as well as the portion of any dues or payments
    made to any tax-exempt organization (such as a trade association) used for an expenditure or contribution that, if made directly by the
    Company, would not be deductible under section 162(e)(1)(B) of the Internal Revenue Code.&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The report shall be made available within 12 months of the annual meeting
    and identify all recipients and the amount paid to each recipient from Company funds. This proposal does not encompass lobbying spending.&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Rationale to vote FOR the Proposal </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>and Rebuttal to Company&rsquo;s Opposition Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As investors we believe transparency and accountability in corporate
spending to influence legislation and regulation are in the best interests of DaVita stockholders. Our aim is not to keep the Company
from spending, but to ensure sufficient transparency for shareholders to be able to evaluate these significant costs, as well as to ensure
sufficient internal accountability to safeguard the alignment of spending with Company mission, values, and ethics. Without a clear system
ensuring accountability, corporate assets can be used to promote public policy objectives which can pose risks to DaVita&rsquo;s reputation
to the detriment of shareholder value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: right; width: 100%"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ff_logo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SUMMARY OF RATIONALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Company reputation is an important component of shareholder value;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">DaVita&rsquo;s 2022 &ldquo;enhanced&rdquo; disclosures remain inadequate;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Indirect political spending through 501(c)(4) social welfare groups presents
potential risks and lacks accountability; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">DaVita could easily provide shareholders the political spending disclosures
requested in this proposal; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Investors are asking for political spending transparency to better understand
risks.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>I.</B></TD><TD><B>Company Reputation is an Important Component of Shareholder Value </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DaVita&rsquo;s failure to provide robust and complete disclosure of
its political spending activities exposes it to potential reputational damage and therefore potential negative impacts on shareholder
value. Heightened scrutiny of corporate political expenditures potentially exposes companies to increased reputational risk, particularly
if sufficient oversight and controls are lacking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">According to a Conference Board study, companies with a high reputation
rank perform better financially than lower ranked companies. Executives also find it is much harder to recover from a reputational failure
than to build and maintain reputation.<SUP>1</SUP> The 2018 Reputation Dividend Report estimates that &ldquo;corporate reputation is now
directly responsible for an average of 38% of market capitalisation across the FTSE 100 &amp; 250.&rdquo;<SUP>2</SUP> Furthermore, the
Ipsos Global Reputation Centre research across 31 countries shows conclusive proof of the relationship between a good reputation and better
business efficiency.<SUP>3</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A 2014 Deloitte survey found 87 percent of executives rated reputation
risk as more important or much more important than other strategic risks their companies are facing, and 88 percent said their companies
are explicitly focusing on managing reputation risk.<SUP>4</SUP> Clearly, corporate reputation has significant impact on shareholder value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> &ldquo;Reputation Risk,&rdquo; <U>The Conference Board</U>,
2007, p. 6, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1077894.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>2</SUP> https://www.provokemedia.com/research/article/link-between-corporate-reputation-market-value-strengthens-study</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>3</SUP> https://www.ipsos.com/sites/default/files/ct/publication/documents/2018-05/unlocking_value_of_reputation-may_2018.pdf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>4</SUP> &ldquo;2014 Global Survey on Reputation Risk,&rdquo; Deloitte,
p. 4, https://www2.deloitte.com/content/dam/Deloitte/pl/Documents/Reports/pl_Reputation_Risk_survey_EN.pdf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: right; width: 100%"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0"><IMG SRC="ff_logo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DaVita has not been immune to reputational issues in recent years,
with our Company reportedly &ldquo;defrauding the federal Medicare program of millions of dollars&rdquo; in 2015.<SUP>5</SUP> Though DaVita
did not admit any wrongdoing at the time, the case was settled for millions. A more recent case was also settled when it came to light
that DaVita had a continued practice between 2005 and 2014 of providing &ldquo;kickbacks [to physicians or physician groups] to induce
the referral of patients to its dialysis clinics.&rdquo; DaVita agreed to pay $350 million to resolve claims that the company had violated
the False Claims Act.<SUP>6</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An employee involved in the case said of his time at DaVita: &ldquo;the
thing that made it so upsetting was the external messaging the company puts out versus what happens behind closed doors.&rdquo;<SUP>7</SUP>
Political activity cannot only create legal risk for a company, but business and reputational risk as well. Most significantly, &ldquo;these
risks include the perception that political contributions &ndash; and other forms of activity &ndash; are at odds with core company values.&rdquo;<SUP>8</SUP>
As shareholders, we believe it is important for DaVita to work to strengthen its reputation for integrity and transparency, by meeting
or surpassing best practice of political spending disclosure. The changes presented by the Company fail to meet this standard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>DaVita Needs to Commit to Political Spending and Dark Money Transparency
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On mission and values regarding integrity, DaVita states &ldquo;We
say what we believe, and we do what we say. We are trusted because we are trustworthy. In our personal, team, and organizational values,
we strive for alignment in what we say and do.&rdquo;<SUP>9</SUP> As investors we believe DaVita could show its commitment to integrity
by disclosing all political spending to shareholders, including all its third-party spending to influence public policy, to ensure that
what our Company does is truly in alignment with what it says.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DaVita&rsquo;s failure to commit to full disclosure of its third-party
spending to influence public policy subjects our Company to unknown reputational risks. Increasingly in this &ldquo;era of intense political
polarization&hellip;companies are subject to ever-greater scrutiny for their political activities.&rdquo;<SUP>10</SUP> We believe DaVita
needs to commit to corporate political responsibility by increasing its political spending disclosure, including all its third-party spending
to influence public policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>_____________________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>5</SUP> https://www.denverpost.com/2015/05/04/davita-will-pay-495-million-to-settle-atlanta-whistle-blower-case/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>6</SUP> https://www.justice.gov/opa/pr/davita-pay-350-million-resolve-allegations-illegal-kickbacks</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>7</SUP> https://www.denverpost.com/2014/10/23/former-davita-insider-helped-build-case-that-led-to-389m-settlement/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>8</SUP> &ldquo;Under a Microscope,&rdquo; <U>The Conference Board</U>,
2021, p. 6, https://conference-board.org/publications/Under-a-Microscope-A-New-Era-of-Scrutiny-for-Corporate-Political-Activity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>9</SUP> https://www.davita.com/about/history-and-culture/mission-and-values</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>10</SUP> &ldquo;Under a Microscope,&rdquo; <U>The Conference Board</U>,
2021, p. 3, https://conference-board.org/publications/Under-a-Microscope-A-New-Era-of-Scrutiny-for-Corporate-Political-Activity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: right; width: 100%"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ff_logo.jpg" ALT=""><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt"><B>II.</B></TD><TD><B>DaVita&rsquo;s 2022 &ldquo;Enhanced&rdquo; Disclosures Remain Inadequate</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">According to the Center for Political Accountability&rsquo;s 2021 CPA-Zicklin
Index, an annual report that &ldquo;<FONT STYLE="background-color: white">benchmarks the political disclosure and accountability policies
and practices for election-related spending of leading U.S. public companies,&rdquo;<SUP>11</SUP> after implementing &ldquo;enhanced&rdquo;
disclosures </FONT>DaVita&rsquo;s Index score increased modestly from 37.1 out of 100 in 2020 to 44.3 out of 100 in 2021; DaVita remains
in the bottom quartile of the third tier.<SUP>12</SUP> DaVita notes in its Statement in Opposition to the Proposal that its marginally
improved Index score, &ldquo;is now above our proxy peer group average.&rdquo; However, based on the peers listed in DaVita&rsquo;s 2021
proxy statement that are also scored in the Zicklin index, DaVita&rsquo;s score lags behind several peers, including Centene, Quest Diagnostics,
Baxter International, and Zimmer Biomet Holdings all of which received a score over 70 out of 100, putting each peer in the top third
of S&amp;P500 companies.<SUP>13</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a well-respected non-partisan, non-profit advocacy organization,
the CPA provides companies with clear guidelines on how to improve political spending transparency and disclosure. Through CPA and their
partners&rsquo; efforts, &ldquo;179 leading public companies have adopted political disclosure and oversight through agreements.&rdquo;<SUP>14</SUP>
Many corporations utilize and adhere to the Zicklin Index to ensure they are up to date on the latest expectations for political spending
disclosure as the index has become a clear way to determine a company&rsquo;s level of transparency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DaVita&rsquo;s continuing poor score directly reflects a lack of transparency
and insufficient political spending disclosure, demonstrating DaVita&rsquo;s policies fall well short of best practice. Specifically,
DaVita does not provide comprehensive disclosure of indirect political spending such as third party, dark money contributions, including
contributions to 527 groups such as governors associations and super PACs, and payments made to tax-exempt organizations such as 501(c)(4)s.
DaVita also does not provide comprehensive disclosure on direct political spending, lacking disclosure on independent political expenditures
made in direct support or opposition to a campaign.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DaVita&rsquo;s political spending information is difficult to obtain,
limited, and is not consolidated. Our Company does not provide investors a comprehensive source where they can learn relevant corporate
direct or indirect political spending activities/relationships, priorities, and whether and how those efforts are supportive of or align
with the Company&rsquo;s strategy and investor interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>_____________________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>11</SUP> https://politicalaccountability.net/index</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>12</SUP> https://www.politicalaccountability.net/wp-content/uploads/2021/11/2021-CPA-Zicklin-Index.pdf</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>13</SUP> https://www.politicalaccountability.net/wp-content/uploads/2021/11/2021-CPA-Zicklin-Index.pdf</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>14</SUP> https://politicalaccountability.net/hifi/files/2020-CPA-Zicklin-Index.pdf</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: right; width: 100%"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ff_logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt"><B>III.</B></TD><TD><B>Indirect Political Spending through 501(c)(4) Social Welfare Groups Presents Potential Risks and Lack Accountability </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While corporate donations to politicians and traditional PACs have
strict limits, corporate payments to trade associations and 501(c)(4) social welfare organizations have no restrictions. This means that
companies can give unlimited amounts to third party groups that spend millions on elections, lobbying and often undisclosed grassroots
activity. This is frequently referred to as dark money spending. According to a 2019 study, trade associations and social welfare groups
spent $535 million on lobbying in 2017 and as much as another $675 million on unregulated efforts to influence public policy.<SUP>15</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>DaVita Doesn&rsquo;t Disclose its 501(c)(4) Social Welfare Organization
Spending (Dark Money), and It Should</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DaVita fails to provide any information on its support for social welfare
- 501(c)(4) - organizations which may use those funds for political purposes. The company has already come under scrutiny for its donations
to the non-profit American Kidney Fund (&ldquo;AKF&rdquo;). AKF has been found to <FONT STYLE="background-color: white">resist giving
aid to patients at clinics that do not donate money to the fund. With Fresenius and DaVita providing nearly 80% of AKF&rsquo;s funding,
DaVita stands to benefit from the organization&rsquo;s tactics, but at significant reputational risk.<SUP>16</SUP> AKF has also been accused
of guiding individuals to switch from &ldquo;low-cost public insurers (that DaVita makes no profit from) to high-cost private insurers
(that DaVita makes a substantial profit from),&rdquo; <SUP>17</SUP> a practice that exposes patients to direct harm.<SUP>18</SUP> A California
bill AB290 intent on closing this &ldquo;charity loophole&rdquo;</FONT> <SUP>19</SUP> declares, among other concerns, that &ldquo;third-party
payment arrangements have proliferated in recent years as a result of health care providers that have demonstrated a willingness to exploit
the Affordable Care Act&rsquo;s guaranteed issue rules for their own financial benefit.&rdquo;<SUP>20</SUP> This directly reflects similar
shareholder concerns regarding the reputational risk of dark money, third party payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>15</SUP> https://theintercept.com/2019/08/06/business-group-spending-on-lobbying-in-washington-is-at-least-double-whats-publicly-reported/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>16</SUP> https://www.nytimes.com/2016/12/25/business/kidney-fund-seen-insisting-on-donations-contrary-to-government-deal.html?module=inline</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>17</SUP> https://hindenburgresearch.com/davita-is-secretly-trying-to-defend-its-charity-scheme-with-a-lobbying-scheme/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>18</SUP> https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB290</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>19</SUP> https://hindenburgresearch.com/davita-is-secretly-trying-to-defend-its-charity-scheme-with-a-lobbying-scheme/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>20</SUP> https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB290</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: right; width: 100%"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ff_logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In response the dialysis industry spent <FONT STYLE="background-color: white">$2.5
million in political spending, including lobbying the Legislature and campaign contributions to support candidates and influence public
opinion, between January and June 2019. DaVita has also given a significant amount to the non-profit organization The Patients and Caregivers
to Protect Dialysis Patients that spent $440,000 in the first half of 2019, primarily on an advertising campaign to sway public opinion
against the California measure.<SUP>21</SUP> DaVita and another major clinic operator, Fresenius, similarly spent nearly $100 million
in 2020 to successfully oppose Proposition 23 in California. The proposition was meant to, &ldquo;require dialysis clinics in California
to always have a licensed physician on-site during operating hours; report data on dialysis-related infections to regulators; obtain consent
from the state before closing down; and prohibit clinics from discriminating against patients based on their source of payment or health
care coverage.&rdquo; <SUP>22</SUP> DaVita remains extremely active in political contributions, spending roughly $138.3 million in California
on ballot measures, campaigns, and various political committees since 2011. This amount is double what the company&rsquo;s competitor,
Fresenius, has spent as well as, &ldquo;more than the combined political contributions of heavyweights Chevron, Uber and Facebook in California
over the past decade.&rdquo;<SUP>23</SUP> Any amounts DaVita contributed to 501(c)(4) groups remains undisclosed and unknown. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Such political expenditures seed
doubt as to whether our company is successfully using its funds &ldquo;solely for promoting the interests of our patients&rdquo; as it
claims in the company&rsquo;s Statement in Opposition, or whether it uses the funds only to ensure company profits. The fact remains that
</FONT>a company loses control of funds contributed indirectly to third-party groups, threatening its ability to act consistently with
its core values and protect its reputation.<SUP>24</SUP> Such blind-spots can result in unintended controversial contributions that can
&ldquo;harm a company&rsquo;s relationship with its customers, employees, and communities, and thereby have a negative impact on the bottom
line.&rdquo;<SUP>25</SUP> Shareholders have no way of knowing if DaVita&rsquo;s contributions to 501(c)(4) welfare organizations, 527
groups, or direct independent expenditures align with company values and thus have no way to anticipate possible reputational risk.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt"><B>IV.</B></TD><TD><B>DaVita Could Easily Provide Shareholders the Political Spending Disclosures Requested in this Proposal </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DaVita states in its Statement in Opposition that additional disclosures,
&ldquo;would not be an efficient use of resources in light of the company&rsquo;s robust existing disclosures.&rdquo; We do not find this
argument compelling or genuine. DaVita has this information readily available and could easily provide it to shareholders in a single
report at minimal expense. While the statement insists that Company lobbying expenditures and political spending, &ldquo;are conducted
solely for promoting the interests of our patients and the Company,&rdquo; shareholders have no way of knowing whether that claim is true
if the Company does not disclose 501(c)(4) social welfare group expenditures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>21</SUP> https://www.latimes.com/california/story/2019-08-24/dialysis-industry-lobbying-to-avoid-oversight-in-california</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>22</SUP> https://fortune.com/2020/11/04/california-prop-proposition-23-results-kidney-dialysis-clinic-requirements-ballot-initiative/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>23</SUP> https://calmatters.org/health/2021/07/dialysis-california-davita/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>24</SUP> https://politicalaccountability.net/hifi/files/reports/cpa-reports/Final_Draft_Collision_Report.pdf</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>25</SUP> &ldquo;Under a Microscope,&rdquo; <U>The Conference Board</U>,
2021, p. 17, https://conference-board.org/publications/Under-a-Microscope-A-New-Era-of-Scrutiny-for-Corporate-Political-Activity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: right; width: 100%"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ff_logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s Statement in Opposition claims DaVita has made
new enhancements to their policy regarding political and lobbying expenditures. However, these efforts continue to fall short of best
practice and fail to meet the shareholder proposal request. DaVita fails to disclose payments made to 501(c)(4), social welfare organizations
and those made to 527, or super PAC, organizations. Lack of disclosure of payments to 501(c)(4) social welfare organizations, and other
dark money payments, remains a huge blind-spot in DaVita&rsquo;s policy, which the Company seems unwilling to address.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In its Statement in Opposition the Company notes that this is &ldquo;the
third consecutive submission by the proponent of a similar proposal, and each time the proponent&rsquo;s proposal has failed to receive
majority support.&rdquo; What the statement fails to include is the proposal filed between 2019 and 2020 received a significant 32.5%,
with an increase to 34.4% in the following 2020 to 2021 proxy season.<SUP>26</SUP> The reason investors have felt compelled to file a
similar proposal many years in a row is due to the company&rsquo;s continued lack of transparency around political contributions, specifically
disclosure of 501(c)(4) social welfare group and other dark money contributions, where DaVita&rsquo;s disclosure falls exceedingly short.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DaVita insists its Board, &ldquo;supports the proposal&rsquo;s stated
objectives of transparency and accountability,&rdquo; but also notes that it believes &ldquo;the local, state, and federal governments
are the appropriate recipients of the proponent&rsquo;s specific positions on political contribution disclosure laws and any reforms they
seek. The company should not be held to a different standard than other groups.&rdquo; We find this statement to demonstrate a lack of
accountability on the part of the Company. Our proposal is not asking for stricter regulation on political contribution disclosures from
the government; as long-term investors we expect companies to provide the necessary transparency around corporate political contributions
to allow investors to better understand, assess, and mitigate risk. Many of DaVita&rsquo;s peers have been held to this standard and have
since increased transparency around these issues for their investors as evident in their higher CPA Zicklin scores.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>26</SUP> <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000927066/000092706620000148/form8-kre2020annualsto.htm">https://www.sec.gov/ix?doc=/Archives/edgar/data/0000927066/000092706620000148/form8-kre2020annualsto.htm</A>;
<A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000927066/000092706621000127/dva-20210610.htm">https://www.sec.gov/ix?doc=/Archives/edgar/data/0000927066/000092706621000127/dva-20210610.htm</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: right; width: 100%"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ff_logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt"><B>V.</B></TD><TD><B>Investors Are Asking for Political Transparency to Better Understand Risks</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Clear policies and board oversight &ndash; coupled with disclosures
to shareholders &ndash; would help mitigate risks and provide greater transparency and accountability thereby allowing investors to assess
potential risks and whether sufficient safeguards are in place to protect our Company&rsquo;s interests as well as the interest of shareholders.
The International Corporate Governance Network (ICGN) representing&nbsp;more than $18 trillion in assets, supports political spending
and lobbying disclosures as best practice, and supports disclosure of any amounts over $10,000.<SUP>27</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The potential reputational risks of DaVita&rsquo;s political spending
and its inadequate political spending disclosure policies highlight the critical need for the Company to improve its disclosures and increase
transparency around its political spending policies and procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Based on the above Rationale, we believe that DaVita&rsquo;s current
political spending disclosures remain inadequate to protect shareholder interests. We urge you to vote FOR Proposal 4, the stockholder
proposal requesting a report on the Company&rsquo;s political expenditures.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jeffery Perkins</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Executive Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Friends Fiduciary Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>This is not a solicitation of authority to vote your proxy. Please
DO NOT send us your proxy card; Friends Fiduciary Corporation is not able to vote your proxies, nor does this communication contemplate
such an event. Friends Fiduciary Corporation urges stockholders to vote for Proposal 4 following the instructions provided on the Company&rsquo;s
proxy mailing.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>27</SUP> https://www.icgn.org/sites/default/files/ICGN%20Political%20Lobbying%20%26%20Donations%202017.pdf</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>ff_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ff_logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M\>1E//$HJ_[N.WK(_*N/X3GGR44W^[CLK]9%'6YE\-VAO]>CDM(1_'-"PS[
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MPV^)OQF^*,G@3X=_#Z[U;Q%J.H3>7H>A69D*OO)=55<A8UYY)VJ!R<5]??\
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M(N7%4\15GK\,/E&G%V_\"E)_,^?XJYL#6P>'I/E^.KII[TZLDGZJ,(I/R/U
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M_P#I6E?(/_!N%9W,_P 7OBO<Q0LR+X)MXV95X#-<,0/J=I_*ON,J=N <3?\
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M:Z7;?QW%T;1KF/C[D=PDT9'?RNHW"M;Q)\;[3P[KNM:&_A^:5M&U+1;-Y%N
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M5% ;GE<<>O-*PSH=Q]:-Q]:0!D]<T;CZT .0_-10 ,#NZ4W!]* #!]*,'TH
M,'TKSWQ'^S3X!\4>*[OQWJ3WG]M76K07L>I(X\RW6*$0BW3C'E&/S 01D^:_
M/- %"P_9;TJQT>WM&^(.M37]C'I<.FZI+#;[[2#3W9[>)4$00C<S%BP)8GKP
M*LP?LP^#(FM9YM:U2XFAFCGN)[B2,M=S+J2ZB\DF$ R\RX(  "G  P*=P,D?
ML:^![/PU-X6T/Q5K%G;W*ZI!<-B&9FL[YT=[8>9&P C,<?EMC<@7J<UV'C/X
M+>&?&]QX4NM4NKR-_".H1W=CY+@"?8@ CER/F3<L;D#'S1+1<+'*Q_L??#[3
M+>S?POK.IZ7?VT,0N-2@\MY+V:.\CNTGF#J59Q,C-T _>OQSQKW'[/\ !J7B
M%?$&M^/-6NVGFL)]9A:WMXUU&:RE,ML[;(P8]K%<A-H8(N>Y+Y@(="_9]U'P
MWX3M?"&D?%K6X[?39%_LW_0[3"1A9$:*51$%N$99.DF[!56&".=>#X)^%[7X
M2Z?\&[6ZO$TS3OLGDS;U,I^SSI.N3C;RR#(   . !QA7 ANO@;HMUX^;QFVO
M:@MK)K46L3:*HC^SR:A';B!)]VW> $53L#;2R!O7*^*?@I9^+O'%GXMU7Q=J
MC6MGJ=KJ,>CL8VA2ZMQB-XV92\0/&]4(#D<]6R7 >GP.\)_:+.6ZDN+A;/Q'
MJ&LK#.J,CS7:3K(C K]P"=MO<$#DUBZ+^R_X:T%M-M;+Q5JW]GV?]F-=Z<WE
M%+Z33R/LLCMLW*5VQA@I 81*#WR7 J#]C[X>(_GP:UJ\<@\-KI DCF08V74=
MS'<XV8\Y'BC&>A5 "#BMNT_9_P!"3X=^)OA[J>OWUW'XMNIKC5KQHH8W\R2-
M(VV*B!%&(Q@8/OFGS!8O>*?A)'K7B72O%7AWQ-<:#<:38SV<4=C8VTD;PRR1
M2,I26-@IW1+@K@]:P]1_9:\!ZA:I;?;KZ+;_ &AYLD0C#3"[OHKUPYV\[9(E
M"YZ*3U)S2N!I_$/X%:'\0M7DU.77+_3X[W35TW6K2Q6/R]0LUE,HB;<I*?,S
MC<A!*R,/0C,UO]EOP)K5M+ VH7T#3R:LTTUOY89UOY1)*A.WD*RKLSTQSFBX
M%&#]CCX7P-<0B[U)[6]OYKB^LY)E*3I)>0W7D'Y<B-6MXD !&$7&>]1ZY^QE
M\,-:T76/#J:AJEI9ZI:SP00VLJ#^SQ+<K<L825)!\P,><\2,.AI\PK&EK/[,
M^B:Q!K&D'QKK=OI.L17IFTFWDC6*.XNK;[/+-G9N;Y27",2@=BV.@'6>$?!^
MO>&XK>#4/'=[J<<"R*8YK&VA$FX(%SY4:\KM.,8SO.<X&%<9O8/I1@^E( P?
M2C!]* '("#R** '44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
+ !10 44 %% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
